Effective therapy of murine models of human leukemia and lymphoma with radiolabeled anti-CD30 antibody, HeFi-1 - Wikidata - wikimedia - TriplyDB

Effective therapy of murine models of human leukemia and lymphoma with radiolabeled anti-CD30 antibody, HeFi-1

Effective therapy of murine models of human leukemia and lymphoma with radiolabeled anti-CD30 antibody, HeFi-1

http://www.wikidata.org/entity/Q24685212

about

Astatine Radiopharmaceuticals: Prospects and Problems Targeting of a developmentally regulated epitope of CD43 for the treatment of acute leukemia.Radioimmunotherapy with α-particle-emitting radionuclides.A novel role for IL-22R1 as a driver of inflammation.Production of [(211)At]-astatinated radiopharmaceuticals and applications in targeted α-particle therapy Epidermal growth factor receptor-targeted radioimmunotherapy of human head and neck cancer xenografts using 90Y-labeled fully human antibody panitumumab.Targeting CD30 in anaplastic large cell lymphoma.CD30 as a therapeutic target for lymphoma.Utilizing CD30 expression as a rational target for therapy of lymphoma.Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions.

P2860

Q33640550-58F5BDB3-C0B5-4C27-B944-8B5BC6CA2B0B Q33944427-67A47D60-4D51-4F00-B728-14825FCF0D56 Q34419562-92FB8DB9-4D4C-4C81-B06F-C5B1BDE68326 Q34542109-C98BE636-75BB-47DE-B53F-CC0B82FA3CDB Q36534262-E5E13FBD-1AFF-4984-8B17-21EB15BECDF9 Q36777329-4A07B290-A99B-4307-9174-A404E395DC2F Q38052082-E639168D-7B2F-4A80-8EC6-6AEF6C70159A Q38138482-671969DC-86D3-46DA-89C3-9EBBCF54D0EF Q45764153-66226FE4-633B-45E3-8000-B73F63FEF136 Q47102763-8CA01DA1-8F02-436D-B2D3-E77594EBAB30

P2860

Effective therapy of murine models of human leukemia and lymphoma with radiolabeled anti-CD30 antibody, HeFi-1

http://www.wikidata.org/entity/Q24685212

description

2007 nî lūn-bûn

@nan

2007 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Effective therapy of murine mo ...... led anti-CD30 antibody, HeFi-1

@ast

Effective therapy of murine mo ...... led anti-CD30 antibody, HeFi-1

@en

Effective therapy of murine mo ...... led anti-CD30 antibody, HeFi-1

@nl

type

label

Effective therapy of murine mo ...... led anti-CD30 antibody, HeFi-1

@ast

Effective therapy of murine mo ...... led anti-CD30 antibody, HeFi-1

@en

Effective therapy of murine mo ...... led anti-CD30 antibody, HeFi-1

@nl

prefLabel

Effective therapy of murine mo ...... led anti-CD30 antibody, HeFi-1

@ast

Effective therapy of murine mo ...... led anti-CD30 antibody, HeFi-1

@en

Effective therapy of murine mo ...... led anti-CD30 antibody, HeFi-1

@nl

P1433

Q24685212-C3C7BBE5-10DC-4C6D-8717-4B02991062FB

P1476

Q24685212-947CEE57-D729-4818-A266-D8796F773937

P2093

Q24685212-1038E3D0-7F47-4D94-A247-218F60C01A23

Q24685212-3EF080AB-A4F3-4AF1-8BF4-D7DD995A3487

Q24685212-616718ED-6BEF-40B1-9530-41D3F10564E1

Q24685212-66066214-F926-42E5-A8A8-EBC62A9EB4C5

Q24685212-7F8F9707-5DB0-497D-84B5-4864CC03FAD5

Q24685212-8B01C830-BC52-40EC-9D68-B45DA4024919

Q24685212-97E4EE32-B23E-480B-ABC1-2787D6BA0E77

Q24685212-ACB7E9E3-4931-4F44-A060-2228B4E1B946

Q24685212-ADC82F64-F1E9-4CA9-A0DE-FEA8D8859157

Q24685212-BF767D0F-ECEC-42EA-BC00-041E86FE4A09

P2860

Q24685212-09D4CD13-09B5-4A5C-883E-FAC747F8B48D

Q24685212-1FEACCE5-00F8-4C3C-9368-0B6D9BAF5C11

Q24685212-23095706-7137-4494-BEC4-7A1811C9681F

Q24685212-3378BC68-9BC8-43BC-8ACF-F2B9600BD429

Q24685212-3CD327ED-E4E3-43DF-B82F-B746594594FF

Q24685212-3CD3FEED-3C9B-426F-A98E-84C1B61F6EA4

Q24685212-3D85BF31-531C-475C-825D-DE42E4ACAB2F

Q24685212-4ECAB384-6261-4C5E-93F4-2826F0D7FDA1

Q24685212-4F4DA408-0179-49D9-A0A2-D1DB39D1C808

Q24685212-5570B0D7-278F-4C2F-AA51-B8981F0594FD

P304

Q24685212-0B06194A-81FD-4A9C-BE54-375A97654910

P31

Q24685212-1AFB49B7-7CCD-415E-9DBC-3451AB1E2312

P356

Q24685212-A13E25BE-D2FF-472F-8F38-D1FF1F465983

P407

Q24685212-8F2711AB-875D-48C2-A21B-130BD1DD1B41

P433

Q24685212-9CF59C95-8901-4194-A427-1F78CCB6AD4E

P478

Q24685212-E45FE80A-52D6-4A97-9F86-65935EE01503

P577

Q24685212-1A5291B7-16FC-434A-B2B2-68CF1795E285

P5875

Q24685212-6CE4FE81-2292-4445-9ABB-935B0A8B8177

P698

Q24685212-C290A725-0668-445B-8D2B-27D764158F4A

P921

Q24685212-922F7502-8BC2-49D7-9AA0-23B6B2430F6E

Q24685212-BC8230F1-6714-425E-8D93-B479FF38CD59

P932

Q24685212-DF626ACD-E29B-4A5C-8E09-61811259A1F9

P356

PNAS.0702496104

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Effective therapy of murine mo ...... led anti-CD30 antibody, HeFi-1

@en

P2093

Carolyn K Goldman

http://www.w3.org/2001/XMLSchema#string

Hiral Patel

http://www.w3.org/2001/XMLSchema#string

John E Janik

http://www.w3.org/2001/XMLSchema#string

Kayhan Garmestani

http://www.w3.org/2001/XMLSchema#string

Martin W Brechbiel

http://www.w3.org/2001/XMLSchema#string

Meili Zhang

http://www.w3.org/2001/XMLSchema#string

Paul S Plascjak

http://www.w3.org/2001/XMLSchema#string

Thomas A Waldmann

http://www.w3.org/2001/XMLSchema#string

Vladimir S Talanov

http://www.w3.org/2001/XMLSchema#string

Zhengsheng Yao

http://www.w3.org/2001/XMLSchema#string

P2860

Immunotherapy: past, present and future

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Pleiotropic signal transduction mediated by human CD30: a member of the tumor necrosis factor receptor (TNFR) family

Antibody-targeted radiation cancer therapy

Anti-CD30 antibody-based therapy.

Tumor therapy with targeted atomic nanogenerators.

The promise of targeted {alpha}-particle therapy.

Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts.

A murine xenograft model for human CD30+ anaplastic large cell lymphoma. Successful growth inhibition with an anti-CD30 antibody (HeFi-1)

CD30 antigen in embryonal carcinoma and embryogenesis and release of the soluble molecule

P304

8444-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0702496104

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

2007-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6342290

http://www.w3.org/2001/XMLSchema#string

P698

17488826

http://www.w3.org/2001/XMLSchema#string

P921

P932

1895969

http://www.w3.org/2001/XMLSchema#string